Join to View Full Profile
3181 SW Sam Jackson Park RdPortland, OR 97239
Phone+1 503-494-6594
Dr. Heinrich is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 1988 - 1991- Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1984 - 1988
Johns Hopkins University School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 2023 - 2027
AK State Medical License 2024 - 2026
ID State Medical License 2022 - 2025
OR State Medical License 1985 - 2025
WA State Medical License 2022 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Portland Monthly Magazine Castle Connolly, 2011
- Join now to see all
Clinical Trials
- S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer Start of enrollment: 2003 Oct 01
- Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Start of enrollment: 2001 Feb 01
- Study of Crenolanib for the Treatment of Patients With Advanced GIST With the D842-related Mutations and Deletions in the PDGFRA Gene Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Clinical Use of Liquid-Based Comprehensive Genomic Profiling in Gastrointestinal Stromal Tumors.Hiba Mechahougui, Lindsey Hildebrand, James Haberberger, Smruthy Sivakumar, Essia Saiji
Laboratory Investigation; a Journal of Technical Methods and Pathology. 2025-02-19 - A Novel Human SDHA-Knockout Cell Line Model for the Functional Analysis of Clinically Relevant SDHA Variants.Jason D Kent, Lillian R Klug, Michael C Heinrich
Clinical Cancer Research. 2024-12-02 - Corrigendum to "Paraganglioma of the Head and Neck: A Review" [Endocrine Practice 29(2) (2023) Pages 141-147].Lyndsey Sandow, Rajat Thawani, Myung Sun Kim, Michael C Heinrich
Endocrine Practice. 2024-08-01
Journal Articles
- Translational Insights into Gastrointestinal Stromal Tumor and Current Clinical AdvancesM C Heinrich, S George, M L Hemming, Annals of Oncology
Lectures
- Clinical activity of avapritinib in ≥ fourth-line (4L+) and PDGFRA Exon 18 gastrointestinal stromal tumors (GIST).ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
- Clinical activity of avapritinib in ≥ fourth-line (4L+) and PDGFRA Exon 18 gastrointestinal stromal tumors (GIST).2019 ASCO Annual Meeting - 6/1/2019
Press Mentions
Two Studies Seek to Go Beyond the GIST of Intestinal Tract CancerAugust 24th, 2021- The Life Raft Group, a Non-Profit Supporting Patients with GIST Cancer, Announces Members of the 2021 Medical Advisory BoardMarch 16th, 2021
FDA Approves Avapritinib for Resectable or Metastatic Gastrointestinal Stromal TumorJanuary 10th, 2020- Join now to see all
Grant Support
- Functional profiling of germline SDH variants associated with cancer susceptibilityPORTLAND VA MEDICAL CENTER2021–2029
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
